全文获取类型
收费全文 | 482274篇 |
免费 | 33650篇 |
国内免费 | 8650篇 |
专业分类
耳鼻咽喉 | 6118篇 |
儿科学 | 9870篇 |
妇产科学 | 11020篇 |
基础医学 | 63429篇 |
口腔科学 | 13592篇 |
临床医学 | 43363篇 |
内科学 | 91654篇 |
皮肤病学 | 10103篇 |
神经病学 | 31632篇 |
特种医学 | 17925篇 |
外国民族医学 | 108篇 |
外科学 | 69524篇 |
综合类 | 31211篇 |
现状与发展 | 24篇 |
一般理论 | 71篇 |
预防医学 | 26981篇 |
眼科学 | 11753篇 |
药学 | 42285篇 |
82篇 | |
中国医学 | 8381篇 |
肿瘤学 | 35448篇 |
出版年
2022年 | 3233篇 |
2021年 | 5982篇 |
2020年 | 4291篇 |
2019年 | 4947篇 |
2018年 | 6883篇 |
2017年 | 5993篇 |
2016年 | 6126篇 |
2015年 | 8170篇 |
2014年 | 11149篇 |
2013年 | 13361篇 |
2012年 | 18717篇 |
2011年 | 19428篇 |
2010年 | 13454篇 |
2009年 | 12170篇 |
2008年 | 16740篇 |
2007年 | 17561篇 |
2006年 | 16926篇 |
2005年 | 15254篇 |
2004年 | 13508篇 |
2003年 | 13375篇 |
2002年 | 12001篇 |
2001年 | 31136篇 |
2000年 | 30973篇 |
1999年 | 25108篇 |
1998年 | 6001篇 |
1997年 | 5154篇 |
1996年 | 4429篇 |
1995年 | 4003篇 |
1994年 | 3553篇 |
1993年 | 3141篇 |
1992年 | 16353篇 |
1991年 | 15058篇 |
1990年 | 14370篇 |
1989年 | 14147篇 |
1988年 | 12738篇 |
1987年 | 12181篇 |
1986年 | 11202篇 |
1985年 | 10419篇 |
1984年 | 6969篇 |
1983年 | 5644篇 |
1982年 | 2752篇 |
1979年 | 5512篇 |
1978年 | 3373篇 |
1977年 | 2980篇 |
1975年 | 2655篇 |
1974年 | 3076篇 |
1973年 | 2890篇 |
1972年 | 2836篇 |
1971年 | 2787篇 |
1969年 | 2554篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
22.
23.
24.
L.‐Q. Zheng X.‐C. Han Y. Huang H.‐W. Li X.‐D. Niu J. Li 《Clinical and experimental dermatology》2015,40(3):293-297
Porocarcinoma is an unusual, locally aggressive and potentially fatal neoplasm. Several cutaneous malignancies have been described in association with porocarcinoma, including squamous cell carcinoma, basal cell carcinoma and tricholemmal carcinoma. Previous reports have indicated that the occurrence of malignant tumours in combination with porocarcinoma is extremely rare, in particular with regard to Bowen disease (BD). We report an uncommon case of porocarcinoma occurring synchronously in a single BD lesion in a 63‐year‐old woman with multiple BD lesions. The clinical and histological findings confirmed this diagnosis. 相似文献
25.
目的调查门诊和普通病房电脑鼠标不同时段的细菌污染情况。方法随机抽取某院门诊及普通病房的各16个电脑鼠标,分别于8∶00、10∶30、13∶00、15∶30进行采样,样本接种培养后对菌落计数并筛查多重耐药菌。结果32个鼠标共计采样128次,最高菌落数达121 CFU/cm2,平均菌落数为23.9 CFU/cm2。随着时间的推移,同一鼠标的细菌计数逐渐增多。不同时段门诊和病房的电脑鼠标菌落数比较,在10∶30、13∶00、15∶30三个时间点,病房鼠标的菌落数均高于门诊(均P≤0.05)。64个病房电脑鼠标标本中检出耐甲氧西林金黄色葡萄球菌(MRSA)和耐碳青霉烯类鲍曼不动杆菌(CRAB)各1株。结论加强鼠标日常清洁消毒及监测工作非常重要,应增加清洁消毒频率或更换长效消毒剂,加强病房环境的清洁消毒。 相似文献
26.
27.
In the 6th Basic Plan for Long-Term Electricity Supply and Demand (6th BPE) for Korea, for the first time, the environmental costs of air pollution caused by oxides of sulfur (SOx), oxides of nitrogen (NOx), and particulate matters (PM) from power plants were estimated and included. However, several deficiencies in evaluating the environmental costs were found. In this study, (1) the validity of the environmental costs used in the 6th BPE was assessed, (2) a systematic approach was suggested and used to improve the environmental costs estimation, and (3) the sensitivity of the cost of generating electricity to the environmental costs by fuel type with the proposed approach was discussed. We found that the applied environmental costs used in the 6th BPE did not fully include the demographic characteristics of Korea. By applying more realistic parameter values, it was found that the newly estimated environmental cost was about 23 times higher than the cost estimated in the original 6th BPE for coal-fired power plants and about 1.5 times higher for liquefied natural gas (LNG)-fired power plants, suggesting that LNG-fired power plants are more economical if using more realistic environmental costs. Thus, it is critical to check the validity of parameter values when calculating environmental costs. 相似文献
28.
29.
Edward J. Holland Walter O. Whitley Kenneth Sall Stephen S. Lane Aparna Raychaudhuri Steven Y. Zhang 《Current medical research and opinion》2016,32(10):1759-1765
Objective: Report efficacy findings from three clinical trials (one phase 2 and two phase 3 [OPUS-1, OPUS-2]) of lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease (DED).Research design and methods: Three 84-day, randomized, double-masked, placebo-controlled trials. Adults (≥18 years) with DED were randomized (1:1) to lifitegrast 5.0% or matching placebo. Changes from baseline to day 84 in signs and symptoms of DED were analyzed.Main outcome measures: Phase 2, pre-specified endpoint: inferior corneal staining score (ICSS; 0–4); OPUS-1, coprimary endpoints: ICSS and visual-related function subscale (0–4 scale); OPUS-2, coprimary endpoints: ICSS and eye dryness score (EDS, VAS; 0–100).Results: Fifty-eight participants were randomized to lifitegrast 5.0% and 58 to placebo in the phase 2 trial; 293 to lifitegrast and 295 to placebo in OPUS-1; 358 to lifitegrast and 360 to placebo in OPUS-2. In participants with mild-to-moderate baseline DED symptomatology, lifitegrast improved ICSS versus placebo in the phase 2 study (treatment effect, 0.35; 95% CI, 0.05–0.65; p?=?0.0209) and OPUS-1 (effect, 0.24; 95% CI, 0.10–0.38; p?=?0.0007). Among more symptomatic participants (baseline EDS ≥40, recent artificial tear use), lifitegrast improved EDS versus placebo in a post hoc analysis of OPUS-1 (effect, 13.34; 95% CI, 2.35–24.33; nominal p?=?0.0178) and in OPUS-2 (effect, 12.61; 95% CI, 8.51–16.70; p?<?0.0001).Limitations: Trials were conducted over 12 weeks; efficacy beyond this period was not assessed.Conclusions: Across three trials, lifitegrast improved ICSS in participants with mild-to-moderate baseline symptomatology in two studies, and EDS in participants with moderate-to-severe baseline symptomatology in two studies. Based on the overall findings from these trials, lifitegrast shows promise as a new treatment option for signs and symptoms of DED. 相似文献
30.
A case of bullous pemphigoid associated with psoriasis vulgaris showing Hailey–Hailey disease‐like histopathological changes in regenerated epidermis without genomic mutation in ATP2C1 or ATP2A2 gene
下载免费PDF全文
![点击此处可从《Journal of the European Academy of Dermatology and Venereology》网站下载免费的PDF全文](/ch/ext_images/free.gif)